 | | | | Roche expects its risdiplam medicine for spinal muscular atrophy (SMA) to get U.S. approval by May, the Swiss drugmaker said on Monday, as it takes on Novartis and Biogen in the lucrative rare disease area. | | |
| | | (This Nov. 23rd story corrects fiscal year of expected regulatory approval in the 10th paragraph to March-end 2021, not March-end 2020) | | |
| | | India will offer incentives to private hospitals to take part in the government's health insurance program, potentially the biggest of its kind in the world, a senior government official told Reuters. | | |
| | | Abu Dhabi has partnered with U.S. non-profit organization Mayo Clinic in a joint venture to operate one of the largest hospitals in the United Arab Emirates as it seeks to become a regional hub for world-class healthcare. | | |
| | | An additional six months of data from a late-stage trial of Takeda Pharmaceutical Co's experimental dengue vaccine again showed it failed to protect against one of the four types of the virus in an important patient group, researchers said on Saturday. | | |
| | | Deaths related to measles, mostly among small children, have more than tripled to 20 in the past week on the Pacific island of Samoa, the government has said eight days after declaring a state of emergency over the outbreak. | | |
| | | When French doctor Christian Chenay saw his first patients in 1951, penicillin was state of the art. | | |
| | | U.S. President Donald Trump on Friday expressed concerns that enacting his administration's proposed ban on many flavored e-cigarette and vaping products would lead to people obtaining them illegally. | | |
| | | (Reuters Health) - People with type 1 diabetes may be more than twice as likely to develop potentially fatal complications when they use cannabis somewhat regularly than when they avoid the drug or rarely indulge, a study suggests. | | |
| | | (Reuters Health) - Teens and young adults have a higher likelihood of taking up marijuana if their parents use the drug, a new study suggests. | | |
| | | The U.S. Food and Drug Administration on Friday approved http://bit.ly/2pIFzi5 Aquestive Therapeutics' treatment for neurological disorder amyotrophic lateral sclerosis (ALS). | | |
|
| |
